As the Date of Application (DoA) gets closer, industry is continuing to adapt to the changes the EU MDR brings. In this exclusive interview, Rebecca Brady from the MedTech Series discusses the clinical expectations of the EU MDR, the future challenges for industry and the impact of the global COVID-19 pandemic on the regulatory deadlines.
Matthias Fink from TÜV SÜD, and Dona Occhipinti from MedSmart, provide their perspectives on how industry can prepare for the DoA but more importantly, life with the EU MDR long term.
